We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Diamond-Based Magnetometers Could Enable New Approaches to Heart Monitoring

By HospiMedica International staff writers
Posted on 22 Sep 2026

Noninvasive cardiac electrophysiology assessment is limited by the challenges of electrode-based electrocardiography and the complexity of magnetocardiography. More...

Skin electrodes can be impractical for patients with burns or fragile skin, while tissue conductivity can distort electrical signals. Contactless magnetic measurements reduce these issues but typically require bulky, costly sensors. To make this approach more practical, researchers have developed a compact diamond-based quantum magnetometer designed to capture cardiac biomagnetic activity at room temperature.

Physicists at Johannes Gutenberg University Mainz (JGU), working within the PRISMA++ Cluster of Excellence and the Helmholtz Institute Mainz, have developed a nitrogen-vacancy (NV) diamond magnetometer for measuring biological magnetic fields. Described in a study published in Science Advances, the sensor uses defects in the diamond crystal formed by a nitrogen atom adjacent to a vacancy in the lattice. Monitoring changes in the energy levels of these NV centers enables the device to detect minute magnetic fields associated with cardiac or neural activity.

The JGU team designed a fiber‑based NV‑diamond magnetometer as a portable endoscope that operates without a magnetic bias field. In contrast, two independently developed systems used by project partners at the Universities of Stuttgart and Freiburg and at Q.ANT GmbH rely on bias fields to suppress environmental interference. All three systems were used to measure the heart’s magnetic field, demonstrating a pathway toward clinical magnetocardiography with room‑temperature quantum sensors and clarifying the remaining engineering steps.

The NV platform offers practical advantages over superconducting quantum interferepnce devices and optically pumped magnetometers because it works at room temperature and uses an ultracompact sensing element. The sensor is a truncated diamond pyramid with a volume below 0.5 cubic millimeters, allowing skin‑level placement and targeted measurements. This enables finer spatial mapping, including potential three‑dimensional reconstruction of cardiac conduction and measurement of fetal heart activity, and it could support early detection of conditions such as myocarditis or epilepsy.

Technical gaps persist in sensitivity and signal‑to‑noise performance compared with established systems, but strategies for improvement are identified. Flux concentrators that channel magnetic flux into the diamond could raise signal amplitude by more than a factor of 100, aided by the NV sensor’s small volume. NV gradiometers that compare signals between two separated sensors may further enable surgical oncology applications, intraoperative nerve monitoring in unshielded rooms, prenatal separation of maternal and fetal rhythms, and portable, room‑temperature magnetoencephalography for neurological diagnostics and brain‑computer interfaces.

The study, “Human Cardiac Measurements with Diamond Magnetometers,” was published in Science Advances on September 16, 2026.

“NV magnetometers are characterized by fast initialization, excellent biocompatibility, and stable operation over a wide temperature range. This makes them particularly attractive for biomedical applications,” said Arne Wickenbrock, coordinator of the DIAQNOS flagship project.

Related Links
Johannes Gutenberg University Mainz
PRISMA++ Cluster of Excellence
Helmholtz Institute Mainz


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Gold Member
12-Channel ECG
CM1200B
Digital Radiography System (Ceiling Free)
Digix CF Series
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Annotation platform for pixel-level labeling of free-text findings in 3D chest CT. (Baharoon M, Luo L, Moritz M, et al. ReXGroundingCT: A 3D chest CT dataset for segmentation of findings from free-text reports. NEJM AI. 2026;3(7). doi:10.1056/AIdbp2501220.)

Public Chest CT Dataset Supports Explainable AI in Diagnostic Radiology

Chest computed tomography scans generate complex three-dimensional images that can be difficult for artificial intelligence systems to explain clearly. Clinicians need to verify AI findings before using... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.